Clinical Trials for Inmunotek

Explore 9 clinical trials worldwide

Showing 1-9 of 9 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Inmunotek

Clinical Trials (9)

NCT07195929
Determination of Blomia Tropicalis Allergen Extract in Prick Test Units
NANot yet recruiting
30 participants
Started: Nov 30, 2025 · Completed: Jan 31, 2027
2 conditions1 sponsor1 location
NCT06790368
Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.
N/ARecruiting
80 participants
Started: Jan 1, 2025 · Completed: Jun 1, 2026
3 conditions1 sponsor3 locations
NCT06782217
Prospective Observational Study to Evaluate the Safety of Immunotherapy as a Treatment for Hymenoptera Venom Allergy
N/ARecruiting
120 participants
Started: Sep 1, 2024 · Completed: Feb 1, 2027
3 conditions1 sponsor9 locations
NCT05641272
Clinical Trial to Evaluate the Efficacy and Safety of Polymerized, Mannan-Conjugated Dermatophagoides Allergen Extract
PHASE2/PHASE3Not yet recruiting
90 participants
Started: Nov 1, 2023 · Completed: Dec 1, 2026
4 conditions3 sponsors1 location
NCT05208060
Study to Evaluate the Ability of Sublingual MV130 to Induce the Expression of Trained Immunity in Peripheral Blood Cells
PHASE1/PHASE2Recruiting
48 participants
Started: Sep 1, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05532566
Quercus Ilex and Quercus Robur Allergen Extracts Standardisation
NARecruiting
30 participants
Started: Jan 24, 2023 · Completed: Nov 30, 2025
3 conditions1 sponsor1 location
NCT04891237
Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen
PHASE3Recruiting
180 participants
Started: Jun 14, 2021 · Completed: Jan 31, 2027
3 conditions1 sponsor32 locations
NCT04898283
Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.
PHASE3Recruiting
180 participants
Started: May 31, 2021 · Completed: Oct 31, 2026
3 conditions1 sponsor27 locations
NCT04435990
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
PHASE3Recruiting
150 participants
Started: Oct 6, 2020 · Completed: Dec 31, 2026
3 conditions2 sponsors32 locations